TPST (STOCKS)

    Tempest Therapeutics, Inc. Common Stock

    $2.270000
    -0.150000 (-6.20%)
    Prev close: $2.420000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Matthew Angel
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $31.94M
    Employees
    5
    P/E (TTM)
    -0.23
    P/B (TTM)
    1.69
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    2
    Strong Buy
    4
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q3)
    $-0.79 $-3.34 +2.5454 +76.31%
    Jun 2025 (Q2)
    $-2.07 $-2.66 +0.5871 +22.10%
    Mar 2025 (Q1)
    $-3.16 $-3.36 +0.1992 +5.93%
    Dec 2024 (Q4)
    $-4.03 $-3.34 -0.6885 -20.60%